Decision-Making Impairment May Precede Limb Apraxia in Corticobasal Degeneration
One patient, Ms. DB, 60 years old, came to our attention in April 2008 for symptoms of bradykinesia and left upper-limb rigidity. She underwent a DaT-SCAN SPECT (bilateral hypocaptation in both putamen nuclei, more marked on the right), an RMI (showing diffuse cortical atrophy, more marked in the right parietal-prefrontal-insular cortex), and an 18-FDG-PET (mild hypometabolism in the right temporo-prefrontal cortex, the right ventral temporal cortex, and the right thalamus). Cognitively, she presented mild executive dysfunction. In March 2009 she developed a left upper-limb apraxia (Movement Imitation Test5: normal score >62; right upper limb: 67; left upper limb: 26). In November 2009 apraxia also affected the right upper limb (Movement Imitation Test: right upper limb: 47; left upper limb not assessable).
Another patient, Mr. EH, a 66-year-old, right-handed man, came to our attention in September 2007 for symptoms of bradykinesia and right upper-limb rigidity. He underwent a DaT-SCAN SPECT (bilateral hypocaptation in both putamen nuclei, more marked on the left, and in the left caudate nucleus) and an 18-FDG-PET (marked bilateral hypometabolism in the parieto-prefrontal cortex, more marked on the left). He presented mild impairment of memory and executive functions. In January 2009 he developed a marked right-limb apraxia (Movement ImitationTest5: left upper limb: 63; right upper limb: 20).
During their baseline assessments, at the onset of parkinsonism and before the appearance of upper-limb apraxia, both CBD patients performed the IGT, and were unable to develop a strategy of choice from more advantageous decks along the task. Mr. EH received a final score of 0, choosing equally from advantageous and disadvantageous decks in the latter two blocks of choices. Ms. DB received a positive final score (+18), selecting almost all advantageous decks in Blocks 2 and 5 and selecting almost all disadvantageous decks in Block 4. This pattern reflected more impulsive, perseverative behavior than a progressive development of an explicit strategy of choice. Instead, patients with de novo Parkinson's disease were able to develop a strategy of choice from more advantageous decks along the IGT.4 These neuropsychological findings suggest that, in CBD patients, decision-making may be impaired early in the course of the disease and may sometimes precede the appearance of upper-limb apraxia. These findings also suggest that the IGT is a useful task to detect early cognitive impairments in patients with parkinsonism whose clinical symptoms are suggestive of CBD.
1. : Corticobasal degeneration. Lancet Neurol 2004; 3:736–443Crossref, Medline, Google Scholar
2. : Corticobasal degeneration as cognitive disorder. Mov Disord 2003; 18:1224–1232Crossref, Medline, Google Scholar
3. : Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7–15Crossref, Medline, Google Scholar
4. : Decision-making in de novo Parkinson's disease. Mov Disord 2010; 29:March, E-pub ahead of printGoogle Scholar
5. : Ideational apraxia. Brain 1988; 111:1173–1185Crossref, Medline, Google Scholar